# Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Randomized Placebo-controlled Study.

> **NCT07492251** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 56 (estimated)

## Conditions studied

- Lichen Penis Planus

## Interventions

- **DRUG:** Upadacitinib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07492251
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-02-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07492251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07492251, "Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Randomized Placebo-controlled Study.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT07492251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*